Key result
First-decreased-then-increased pulse pressure trajectory linked to ~66% greater ESRD risk versus first-increased-then-decreased trajectory.
Why the study?
The trajectories of pulse pressure might affect the prognosis of malignant hypertensive nephropathy, but their association with end-stage renal disease risk was unclear.
Does pulse pressure trajectory pattern affect the risk of end-stage renal disease in patients with malignant hypertensive nephropathy?
Cohort (n=203)
Does pulse pressure trajectory pattern affect the risk of end-stage renal disease in patients with malignant hypertensive nephropathy?
In patients with malignant hypertensive nephropathy, a 'first-decreased-then-increased' pulse pressure trajectory prior to biopsy is associated with a 66% greater risk of developing end-stage renal disease compared to a 'first-increased-then-decreased' trajectory.
Answers are grounded in this paper and cite their sources.
PP trajectories may stratify ESRD risk in MHN; leaves open whether targeting them improves outcomes.
OBJECTIVE: The trajectories of pulse pressure (PP) might affect the prognosis of malignant hypertensive nephropathy (MHN). We aimed to describe the association between PP trajectories and the future risk of end-stage renal disease and to identify and compare the associated patient characteristics of any distinct trajectory patterns in MHN patients. METHODS: Patients with newly diagnosed biopsy-proven MHN 2010-2015 were included. Latent class growth analysis was applied to the PP measured over 3 years prior to biopsy to identify distinct trajectories. Concurrent systolic blood pressure, diastolic blood pressure, plasma creatinine, and 24-h urine protein measurements for each trajectory group were modelled using generalized estimating equations. The risk of end-stage renal disease (with kidney replacement therapy as a proxy) was estimated using Logistic regression. RESULTS: Two hundred three patients were included (median-age 34 years, and 19.7% female). A two-group cubic model was optimal, with trajectories distinguished by the rate of PP and absolute level at final measurement. Trajectory Group-1 (n = 84) was characterized by 'first-increased-then-decreased' PP and trajectory Group-2 (n = 119) was characterized by 'first-decreased-then-increased' PP over 3 years prior to biopsy. Systolic and diastolic blood pressures, plasma creatinine, and 24-h urine protein were differed by the trajectory group. Baseline characteristics differed substantially between trajectory groups. Compared with Group-1, Group-2 had a 66% greater risk of developing into end-stage renal disease in the subsequent 3 years. CONCLUSIONS: Two distinct 3-year trajectories for PP exist with MHN. Early introduction of intensive antihypertensive treatment might delay the development of end-stage renal disease among patients with malignant hypertension.
No takes yet. Share an insight, caveat, or question.
Zhuang et al. (2020) conducted a cohort in Malignant hypertensive nephropathy (n=203). Pulse pressure trajectory Group-2 ('first-decreased-then-increased') vs. Trajectory Group-1 ('first-increased-then-decreased') was evaluated on End-stage renal disease (66% greater risk). A 'first-decreased-then-increased' pulse pressure trajectory was associated with a 66% higher risk of end-stage renal disease over 3 years compared to a 'first-increased-then-decreased' trajectory.
Synapse has enriched 10 related papers. Consider them for comparative context: